Merck & Co., Inc. · Whitehouse Station, NJ United States (NYSE: MRK)
Key Merck & Co., Inc. Financials
| Company Type | Public -(NYSE: MRK) Headquarters |
|---|---|
| Fiscal Year-End | December |
| 2011 Sales (mil.) | $48,047.0 |
| 2010 Employees | 94,000 |
Merck & Co., Inc. Stock Quote (NYSE: MRK)
| Latest 02/15/12 11:41:16 EST | Change ($) | Change (%) | High | Low |
|---|---|---|---|---|
| $38.08 |  -0.130 | -0.340 | $38.28 | $37.91 |
Quotes delayed 15 minutes for NASDAQ, 20 minues for NYSE and AMEX. Market Data provided by Interactive Data. Powered and Implemented by Interactive Data Managed Solutions. |
Merck & Co., Inc. Income Statement
| Dec 11 | Dec 10 | Dec 09 | |
| Revenue | 48,047.0 | 45,987.0 | 27,428.3 |
| Cost of Goods Sold | 16,871.0 | 18,396.0 | 9,018.9 |
| Gross Profit | 31,176.0 | 27,591.0 | 18,409.4 |
| Gross Profit Margin | 64.9% | 60% | 67.1% |
| SG&A Expense | 13,733.0 | 13,245.0 | 8,543.2 |
| Depreciation & Amortization | -- | 7,381.0 | 2,576.0 |
| Operating Income | 7,670.0 | 2,370.0 | 2,387.3 |
| Operating Margin | 16% | 5.2% | 8.7% |
| Nonoperating Income | 214.0 | (85.0) | 13,152.3 |
| Nonoperating Expenses | (550.0) | (632.0) | (247.8) |
| Income Before Taxes | 7,334.0 | 1,653.0 | 15,291.8 |
| Income Taxes | 942.0 | 671.0 | 2,267.6 |
| Net Income After Taxes | 6,392.0 | 982.0 | 13,024.2 |
| Continuing Operations | 6,272.0 | 861.0 | 12,901.3 |
| Discontinued Operations | -- | -- | -- |
| Total Operations | 6,272.0 | 861.0 | 12,901.3 |
| Total Net Income | 6,272.0 | 861.0 | 12,901.3 |
| Net Profit Margin | 13.1% | 1.9% | 47% |
| Diluted EPS from Total Net Income | 2.02 | 0.28 | 5.65 |
| Dividends per Share | 1.56 | 1.52 | 1.52 |
All amounts in millions of US Dollars except per share amounts.
Merck & Co., Inc. Balance Sheet
| Assets | Dec 11 | Dec 10 | Dec 09 |
| Current Assets | |||
| Cash | -- | 10,900.0 | 9,311.4 |
| Net Receivables | -- | 7,344.0 | 6,602.9 |
| Inventories | -- | 5,868.0 | 8,055.3 |
| Other Current Assets | -- | 4,952.0 | 4,459.0 |
| Total Current Assets | -- | 29,064.0 | 28,428.6 |
| Net Fixed Assets | -- | 17,082.0 | 18,273.5 |
| Other Noncurrent Assets | -- | 59,635.0 | 65,387.6 |
| Total Assets | -- | 105,781.0 | 112,089.7 |
| Liabilities | Dec 11 | Dec 10 | Dec 09 |
| Current Liabilities | |||
| Accounts Payable | -- | 2,308.0 | 2,236.9 |
| Short-Term Debt | -- | 2,400.0 | 1,379.2 |
| Other Current Liabilities | -- | 10,933.0 | 12,134.6 |
| Total Current Liabilities | -- | 15,641.0 | 15,750.7 |
| Long-Term Debt | -- | 15,482.0 | 16,074.9 |
| Other Noncurrent Liabilities | -- | 20,282.0 | 21,206.1 |
| Total Liabilities | -- | 51,405.0 | 53,031.7 |
| Shareholder's Equity | |||
| Preferred Stock Equity | -- | -- | -- |
| Common Stock Equity | -- | 54,376.0 | 59,058.0 |
| Total Equity | -- | 54,376.0 | 59,058.0 |
| Shares Outstanding (thou.) | 3,047,921.4 | 3,082,106.8 | 3,108,222.6 |
All amounts in millions of US Dollars except per share amounts.
Merck & Co., Inc. Cash Flow Statement
| Dec 11 | Dec 10 | Dec 09 | |
| Net Operating Cash Flow | -- | 10,822 | 3,392 |
| Net Investing Cash Flow | -- | (3,497.0) | 3,156.0 |
| Net Financing Cash Flow | (5,441.0) | (1,638.3) | |
| Net Change in Cash | 1,589.0 | 4,943.1 | |
| Depreciation & Amortization | 7,381.0 | 2,576.0 | |
| Capital Expenditures | (1,678.0) | (1,460.6) | |
| Cash Dividends Paid | (4,853.0) | (3,479.1) |
All amounts in millions of US Dollars except per share amounts.